Syn2bio Company Description

Syn2bio S.A. operates as a biotechnology company.

It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease.

It also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product.

Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

Syn2bio S.A.

Country	Poland
Founded	2025
Industry	Biotechnology
Sector	Healthcare
CEO	Cezary Kozanecki

Contact Details

Address: ul. J. P. Dziekonskiego 3 Warsaw, 00-728 Poland
Phone	48 223 27 09 10
Website	syn2bio.pl

Stock Details

Ticker Symbol	S2B
Exchange	Warsaw Stock Exchange
Reporting Currency	PLN
SIC Code	2835

Key Executives

Name	Position
Cezary Dariusz Kozanecki	Chief Executive Officer and Chairman of the Management Board
Anna Szymanska	Member of the Management Board
Sawa Zuzanna Zarebinska	Secretary and Member of the Supervisory Board